BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Reisinger KW, Bosmans JW, Uittenbogaart M, Alsoumali A, Poeze M, Sosef MN, Derikx JP. Loss of Skeletal Muscle Mass During Neoadjuvant Chemoradiotherapy Predicts Postoperative Mortality in Esophageal Cancer Surgery. Ann Surg Oncol 2015;22:4445-52. [PMID: 25893413 DOI: 10.1245/s10434-015-4558-4] [Cited by in Crossref: 78] [Cited by in F6Publishing: 76] [Article Influence: 11.1] [Reference Citation Analysis]
Number Citing Articles
1 Goncalves MD, Taylor S, Halpenny DF, Schwitzer E, Gandelman S, Jackson J, Lukose A, Plodkowski AJ, Tan KS, Dunphy M, Jones LW, Downey RJ. Imaging skeletal muscle volume, density, and FDG uptake before and after induction therapy for non-small cell lung cancer. Clin Radiol 2018;73:505.e1-8. [PMID: 29317048 DOI: 10.1016/j.crad.2017.12.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
2 Onishi S, Tajika M, Tanaka T, Yamada K, Abe T, Higaki E, Hosoi T, Inaba Y, Muro K, Shimizu M, Niwa Y. Prognostic Impact of Sarcopenic Obesity after Neoadjuvant Chemotherapy Followed by Surgery in Elderly Patients with Esophageal Squamous Cell Carcinoma. J Clin Med 2020;9:E2974. [PMID: 32942595 DOI: 10.3390/jcm9092974] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
3 Sasaki M, Miyoshi N, Fujino S, Ogino T, Takahashi H, Uemura M, Matsuda C, Yamamoto H, Mizushima T, Mori M, Doki Y. The Geriatric Nutritional Risk Index predicts postoperative complications and prognosis in elderly patients with colorectal cancer after curative surgery. Sci Rep 2020;10:10744. [PMID: 32612136 DOI: 10.1038/s41598-020-67285-y] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
4 Boutin RD, Katz JR, Chaudhari AJ, Yabes JG, Hirschbein JS, Nakache YP, Seibert JA, Lamba R, Fananapazir G, Canter RJ, Lenchik L. Association of adipose tissue and skeletal muscle metrics with overall survival and postoperative complications in soft tissue sarcoma patients: an opportunistic study using computed tomography. Quant Imaging Med Surg 2020;10:1580-9. [PMID: 32742953 DOI: 10.21037/qims.2020.02.09] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
5 Dang C, Wang M, Qin T, Qin R. How can we better predict the prognosis of patients with pancreatic cancer undergoing surgery using an immune-nutritional scoring system? Surgery 2022:S0039-6060(21)01197-1. [PMID: 35086728 DOI: 10.1016/j.surg.2021.12.009] [Reference Citation Analysis]
6 Noh JH, Na HK, Kim YH, Song HJ, Kim HR, Choi KD, Lee GH, Jung HY. Influence of Preoperative Nutritional Status on Patients Who Undergo Upfront Surgery for Esophageal Squamous Cell Carcinoma. Nutr Cancer 2022;:1-10. [PMID: 35234093 DOI: 10.1080/01635581.2022.2042573] [Reference Citation Analysis]
7 Kawakita Y, Motoyama S, Sato Y, Wakita A, Nagaki Y, Imai K, Minamiya Y. Decreases in the Psoas Muscle Index Correlate More Strongly with Survival than Other Prognostic Markers in Esophageal Cancer After Neoadjuvant Chemoradiotherapy Plus Esophagectomy. World J Surg 2020;44:1559-68. [PMID: 31907570 DOI: 10.1007/s00268-019-05344-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
8 Derstine BA, Holcombe SA, Ross BE, Wang NC, Su GL, Wang SC. Optimal body size adjustment of L3 CT skeletal muscle area for sarcopenia assessment. Sci Rep 2021;11:279. [PMID: 33431971 DOI: 10.1038/s41598-020-79471-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Chae MS, Moon KU, Jung J, Choi HJ, Chung HS, Park CS, Lee J, Choi JH, Hong SH. Perioperative loss of psoas muscle is associated with patient survival in living donor liver transplantation: Chae et al. Liver Transpl 2018;24:623-33. [DOI: 10.1002/lt.25022] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 4.5] [Reference Citation Analysis]
10 Srpcic M, Jordan T, Popuri K, Sok M. Sarcopenia and myosteatosis at presentation adversely affect survival after esophagectomy for esophageal cancer. Radiol Oncol 2020;54:237-46. [PMID: 32229679 DOI: 10.2478/raon-2020-0016] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
11 Dietz MV, van Kooten JP, van Vugt JLA, Brandt-Kerkhof ARM, Verhoef C, Madsen EVE. The Impact of Low Skeletal Muscle Mass on Short- and Long-Term Outcomes After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy. Ann Surg Oncol 2022. [PMID: 35650370 DOI: 10.1245/s10434-022-11941-2] [Reference Citation Analysis]
12 Ryan AM, Sullivan ES. Impact of musculoskeletal degradation on cancer outcomes and strategies for management in clinical practice. Proc Nutr Soc 2021;80:73-91. [PMID: 32981540 DOI: 10.1017/S0029665120007855] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
13 West MA, Baker WC, Rahman S, Munro A, Jack S, Grocott MP, Underwood TJ, Levett DZ; Fit-4-Surgery Consortium. Cardiopulmonary exercise testing has greater prognostic value than sarcopenia in oesophago-gastric cancer patients undergoing neoadjuvant therapy and surgical resection. J Surg Oncol 2021. [PMID: 34463378 DOI: 10.1002/jso.26652] [Reference Citation Analysis]
14 Takahashi K, Watanabe M, Kozuki R, Toihata T, Okamura A, Imamura Y, Mine S, Ishizuka N. Prognostic Significance of Skeletal Muscle Loss During Early Postoperative Period in Elderly Patients with Esophageal Cancer. Ann Surg Oncol 2019;26:3727-35. [DOI: 10.1245/s10434-019-07616-0] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
15 Nakatani M, Migita K, Matsumoto S, Wakatsuki K, Ito M, Nakade H, Kunishige T, Kitano M, Kanehiro H. Prognostic significance of the prognostic nutritional index in esophageal cancer patients undergoing neoadjuvant chemotherapy. Dis Esophagus 2017;30:1-7. [PMID: 28575242 DOI: 10.1093/dote/dox020] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 6.8] [Reference Citation Analysis]
16 Järvinen T, Ilonen I, Kauppi J, Salo J, Räsänen J. Loss of skeletal muscle mass during neoadjuvant treatments correlates with worse prognosis in esophageal cancer: a retrospective cohort study. World J Surg Oncol 2018;16:27. [PMID: 29433514 DOI: 10.1186/s12957-018-1327-4] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 7.3] [Reference Citation Analysis]
17 Villéger R, Lopès A, Carrier G, Veziant J, Billard E, Barnich N, Gagnière J, Vazeille E, Bonnet M. Intestinal Microbiota: A Novel Target to Improve Anti-Tumor Treatment? Int J Mol Sci 2019;20:E4584. [PMID: 31533218 DOI: 10.3390/ijms20184584] [Cited by in Crossref: 35] [Cited by in F6Publishing: 30] [Article Influence: 11.7] [Reference Citation Analysis]
18 Sakai M, Sohda M, Uchida S, Yamaguchi A, Watanabe T, Saito H, Ubukata Y, Nakazawa N, Kuriyama K, Sano A, Ogawa H, Yokobori T, Shirabe K, Saeki H. ASO Author Reflections: Impact of the Ratio of the Visceral Fat Area (VFA) to Psoas Muscle Area (PMA) (V/P Ratio) on Survival for Patients with Surgically Resected Esophageal Cancer. Ann Surg Oncol 2022. [PMID: 35441306 DOI: 10.1245/s10434-022-11615-z] [Reference Citation Analysis]
19 Bossi P, Delrio P, Mascheroni A, Zanetti M. The Spectrum of Malnutrition/Cachexia/Sarcopenia in Oncology According to Different Cancer Types and Settings: A Narrative Review. Nutrients 2021;13:1980. [PMID: 34207529 DOI: 10.3390/nu13061980] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
20 Conceição MS, Derchain S, Vechin FC, Telles G, Maginador GF, Sarian LO, Libardi CA, Ugrinowitsch C. Maintenance of Muscle Mass and Cardiorespiratory Fitness to Cancer Patients During COVID-19 Era and After SARS-CoV-2 Vaccine. Front Physiol 2021;12:655955. [PMID: 34248658 DOI: 10.3389/fphys.2021.655955] [Reference Citation Analysis]
21 Ruby L, Sanabria SJ, Saltybaeva N, Frauenfelder T, Alkadhi H, Rominger MB. Comparison of ultrasound speed-of-sound of the lower extremity and lumbar muscle assessed with computed tomography for muscle loss assessment. Medicine (Baltimore) 2021;100:e25947. [PMID: 34032704 DOI: 10.1097/MD.0000000000025947] [Reference Citation Analysis]
22 Velho S, Costa Santos MP, Cunha C, Agostinho L, Cruz R, Costa F, Garcia M, Oliveira P, Maio R, Baracos VE, Cravo M. Body Composition Influences Post-Operative Complications and 90-Day and Overall Survival in Pancreatic Surgery Patients. GE Port J Gastroenterol 2020;28:13-25. [PMID: 33564701 DOI: 10.1159/000507206] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
23 Prado CM, Cushen SJ, Orsso CE, Ryan AM. Sarcopenia and cachexia in the era of obesity: clinical and nutritional impact. Proc Nutr Soc. 2016;75:188-198. [PMID: 26743210 DOI: 10.1017/s0029665115004279] [Cited by in Crossref: 114] [Cited by in F6Publishing: 52] [Article Influence: 19.0] [Reference Citation Analysis]
24 Palmela C, Velho S, Agostinho L, Branco F, Santos M, Santos MP, Oliveira MH, Strecht J, Maio R, Cravo M, Baracos VE. Body Composition as a Prognostic Factor of Neoadjuvant Chemotherapy Toxicity and Outcome in Patients with Locally Advanced Gastric Cancer. J Gastric Cancer 2017;17:74-87. [PMID: 28337365 DOI: 10.5230/jgc.2017.17.e8] [Cited by in Crossref: 54] [Cited by in F6Publishing: 50] [Article Influence: 10.8] [Reference Citation Analysis]
25 Wang P, Wang S, Li X, Lin G, Ma Y, Xiao R, Li H, Qiu M, Yang F. Skeletal muscle wasting during neoadjuvant therapy as a prognosticator in patients with esophageal and esophagogastric junction cancer: A systematic review and meta-analysis. Int J Surg 2022;97:106206. [PMID: 34990833 DOI: 10.1016/j.ijsu.2021.106206] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Horii N, Kosaka T, Fujiwara R, Sato S, Akiyama H, Kunisaki C, Endo I. Psoas muscle depletion during preoperative chemotherapy for advanced gastric cancer has a negative impact on long-term outcomes after gastrectomy. Asia Pac J Clin Oncol 2021. [PMID: 33644991 DOI: 10.1111/ajco.13514] [Reference Citation Analysis]
27 Nishigori T, Okabe H, Tanaka E, Tsunoda S, Hisamori S, Sakai Y. Sarcopenia as a predictor of pulmonary complications after esophagectomy for thoracic esophageal cancer. J Surg Oncol 2016;113:678-84. [PMID: 26936808 DOI: 10.1002/jso.24214] [Cited by in Crossref: 78] [Cited by in F6Publishing: 71] [Article Influence: 13.0] [Reference Citation Analysis]
28 van Egmond MA, van der Schaaf M, Hagens ERC, van Laarhoven HWM, van Berge Henegouwen MI, Haverkort EB, Engelbert RHH, Gisbertz SS. Muscle Strength Is Associated With Muscle Mass in Patients With Esophageal Cancer Awaiting Surgery. Journal of Geriatric Physical Therapy 2020;43:82-8. [DOI: 10.1519/jpt.0000000000000200] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
29 Hopkins JJ, Reif R, Bigam D, Baracos VE, Eurich DT, Sawyer MM. Change in Skeletal Muscle Following Resection of Stage I-III Colorectal Cancer is Predictive of Poor Survival: A Cohort Study. World J Surg 2019;43:2518-26. [PMID: 31222643 DOI: 10.1007/s00268-019-05054-3] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 7.0] [Reference Citation Analysis]
30 Guinan EM, Dowds J, Donohoe C, Reynolds JV, Hussey J. The physiotherapist and the esophageal cancer patient: from prehabilitation to rehabilitation. Dis Esophagus 2017;30:1-12. [PMID: 27862675 DOI: 10.1111/dote.12514] [Cited by in Crossref: 6] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
31 Hagens ERC, Feenstra ML, van Egmond MA, van Laarhoven HWM, Hulshof MCCM, Boshier PR, Low DE, van Berge Henegouwen MI, Gisbertz SS. Influence of body composition and muscle strength on outcomes after multimodal oesophageal cancer treatment. J Cachexia Sarcopenia Muscle 2020;11:756-67. [PMID: 32096923 DOI: 10.1002/jcsm.12540] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
32 Lyon TD, Frank I, Takahashi N, Boorjian SA, Moynagh MR, Shah PH, Tarrell RF, Cheville JC, Viers BR, Tollefson MK. Sarcopenia and Response to Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer. Clin Genitourin Cancer 2019;17:216-222.e5. [PMID: 31060857 DOI: 10.1016/j.clgc.2019.03.007] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
33 Oguma J, Ozawa S, Ishiyama K, Daiko H. Clinical significance of sarcopenic dysphagia for patients with esophageal cancer undergoing esophagectomy: A review. Annals of Gastroent Surgery. [DOI: 10.1002/ags3.12603] [Reference Citation Analysis]
34 Allen SK, Brown V, White D, King D, Hunt J, Wainwright J, Emery A, Hodge E, Kehinde A, Prabhu P, Rockall TA, Preston SR, Sultan J. Multimodal Prehabilitation During Neoadjuvant Therapy Prior to Esophagogastric Cancer Resection: Effect on Cardiopulmonary Exercise Test Performance, Muscle Mass and Quality of Life-A Pilot Randomized Clinical Trial. Ann Surg Oncol 2021. [PMID: 34725764 DOI: 10.1245/s10434-021-11002-0] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
35 Zhang Y, Li Z, Jiang L, Xue Z, Ma Z, Kang W, Ye X, Liu Y, Jin Z, Yu J. Marked loss of adipose tissue during neoadjuvant therapy as a predictor for poor prognosis in patients with gastric cancer: A retrospective cohort study. J Hum Nutr Diet 2021;34:585-94. [PMID: 33491826 DOI: 10.1111/jhn.12861] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
36 Cho KA, Choi DW, Kim YH, Kim J, Ryu KH, Woo SY. Mesenchymal Stem Cell-Derived Exosomes Protect Muscle Loss by miR-145-5p Activity Targeting Activin A Receptors. Cells 2021;10:2169. [PMID: 34440938 DOI: 10.3390/cells10082169] [Reference Citation Analysis]
37 Takao K, Konishi H, Fujiwara H, Shiozaki A, Shoda K, Kosuga T, Kubota T, Arita T, Morimura R, Murayama Y, Kuriu Y, Ikoma H, Nakanishi M, Okamoto K, Otsuji E. Clinical Significance of Prognostic Nutritional Index in the Treatment of Esophageal Squamous Cell Carcinoma. In Vivo 2020;34:3451-7. [PMID: 33144453 DOI: 10.21873/invivo.12184] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
38 Hikage M, Taniyama Y, Sakurai T, Sato C, Takaya K, Okamoto H, Konno T, Ujiie N, Naitoh T, Unno M, Kamei T. The Influence of the Perioperative Nutritional Status on the Survival Outcomes for Esophageal Cancer Patients with Neoadjuvant Chemotherapy. Ann Surg Oncol 2019;26:4744-53. [PMID: 31440925 DOI: 10.1245/s10434-019-07742-9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
39 Xue Y, Zhou X, Xue L, Zhou R, Luo J. The role of pretreatment prognostic nutritional index in esophageal cancer: A meta-analysis. J Cell Physiol. 2019;234:19655-19662. [PMID: 31344989 DOI: 10.1002/jcp.28565] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
40 van Grinsven J, van Vugt JLA, Gharbharan A, Bollen TL, Besselink MG, van Santvoort HC, van Eijck CHJ, Boerma D; Dutch Pancreatitis Study Group. The Association of Computed Tomography-Assessed Body Composition with Mortality in Patients with Necrotizing Pancreatitis. J Gastrointest Surg 2017;21:1000-8. [PMID: 28299618 DOI: 10.1007/s11605-016-3352-3] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
41 Yoon HG, Oh D, Ahn YC, Noh JM, Pyo H, Cho WK, Song YM, Park M, Hwang NY, Sun JM, Kim HK, Zo JI, Shim YM. Prognostic Impact of Sarcopenia and Skeletal Muscle Loss During Neoadjuvant Chemoradiotherapy in Esophageal Cancer. Cancers (Basel) 2020;12:E925. [PMID: 32290037 DOI: 10.3390/cancers12040925] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
42 Yamashita M, Kamiya K, Matsunaga A, Kitamura T, Hamazaki N, Ichikawa T, Uchida S, Noda T, Yanagi N, Maekawa E, Yamaoka-Tojo M, Ako J, Miyaji K. Features of trunk muscle wasting during acute care and physical function recovery with aortic disease. J Cachexia Sarcopenia Muscle 2022;13:1054-63. [PMID: 35178890 DOI: 10.1002/jcsm.12935] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
43 Kita R, Miyata H, Sugimura K, Tanaka K, Makino T, Yamashita K, Yamasaki M, Motoori M, Shiraishi O, Kimura Y, Yasuda T, Yano M, Doki Y. Clinical effect of enteral nutrition support during neoadjuvant chemotherapy on the preservation of skeletal muscle mass in patients with esophageal cancer. Clin Nutr 2021;40:4380-5. [PMID: 33526287 DOI: 10.1016/j.clnu.2021.01.007] [Reference Citation Analysis]
44 Wong J, Tran LT, Lynch KA, Wood LJ. Dexamethasone exacerbates cytotoxic chemotherapy induced lethargy and weight loss in female tumor free mice. Cancer Biol Ther 2018;19:87-96. [PMID: 29231783 DOI: 10.1080/15384047.2017.1394549] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
45 Maurício SF, Xiao J, Prado CM, Gonzalez MC, Correia MITD. Different nutritional assessment tools as predictors of postoperative complications in patients undergoing colorectal cancer resection. Clin Nutr 2018;37:1505-11. [PMID: 28918167 DOI: 10.1016/j.clnu.2017.08.026] [Cited by in Crossref: 26] [Cited by in F6Publishing: 20] [Article Influence: 5.2] [Reference Citation Analysis]
46 Bozzetti F. Chemotherapy-Induced Sarcopenia. Curr Treat Options Oncol 2020;21:7. [PMID: 32002684 DOI: 10.1007/s11864-019-0691-9] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 7.5] [Reference Citation Analysis]
47 Ariën F, Baitar A, Perkisas S, Vandewoude M, De Cock AM. The association between muscle mass and the degree of myosteatosis of the psoas muscle and mortality in older patients with cancer. J Geriatr Oncol 2021;12:85-90. [PMID: 32771287 DOI: 10.1016/j.jgo.2020.06.024] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
48 Teigen LM, Kuchnia AJ, Nagel E, Deuth C, Vock DM, Mulasi U, Earthman CP. Impact of Software Selection and ImageJ Tutorial Corrigendum on Skeletal Muscle Measures at the Third Lumbar Vertebra on Computed Tomography Scans in Clinical Populations. Journal of Parenteral and Enteral Nutrition 2018;42:933-41. [DOI: 10.1002/jpen.1036] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.2] [Reference Citation Analysis]
49 Possner M, Alsaied T, Siddiqui S, Morales D, Trout AT, Veldtman G. Abdominal Skeletal Muscle Index as a Potential Novel Biomarker in Adult Fontan Patients. CJC Open 2020;2:55-61. [PMID: 32190826 DOI: 10.1016/j.cjco.2019.12.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
50 Sato S, Kunisaki C, Suematsu H, Tanaka Y, Miyamoto H, Kosaka T, Yukawa N, Tanaka K, Sato K, Akiyama H, Endo I. Impact of Sarcopenia in Patients with Unresectable Locally Advanced Esophageal Cancer Receiving Chemoradiotherapy. In Vivo 2018;32:603-10. [PMID: 29695567 DOI: 10.21873/invivo.11282] [Cited by in Crossref: 5] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
51 Ishihara H, Takagi T, Kondo T, Fukuda H, Yoshida K, Iizuka J, Tanabe K. Effect of Changes in Skeletal Muscle Mass on Oncological Outcomes During First-Line Sunitinib Therapy for Metastatic Renal Cell Carcinoma. Target Oncol 2018;13:745-55. [PMID: 30328067 DOI: 10.1007/s11523-018-0600-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
52 Lee HS, Kim SY, Chung MJ, Park JY, Bang S, Park SW, Song SY. Skeletal Muscle Mass Predicts Poor Prognosis in Patients with Advanced Pancreatic Cancer Undergoing Second-Line FOLFIRINOX Chemotherapy. Nutrition and Cancer 2019;71:1100-7. [DOI: 10.1080/01635581.2019.1597906] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
53 Xu X, Jiang X, Xu Q, Xu H, Luo J, Yao C, Ding L, Zhu S. Skeletal Muscle Change During Neoadjuvant Therapy and Its Impact on Prognosis in Patients With Gastrointestinal Cancers: A Systematic Review and Meta-Analysis. Front Oncol 2022;12:892935. [DOI: 10.3389/fonc.2022.892935] [Reference Citation Analysis]
54 Marker RJ, Peters JC, Purcell WT, Jankowski CA. Effects of Preoperative Exercise on Physical Fitness and Body Composition in Pancreatic Cancer Survivors Receiving Neoadjuvant Therapy: A Case Series. Rehabilitation Oncology 2018;36:E1-9. [DOI: 10.1097/01.reo.0000000000000122] [Cited by in Crossref: 8] [Article Influence: 2.0] [Reference Citation Analysis]
55 Reijneveld EAE, Bor P, Dronkers JJ, Argudo N, Ruurda JP, Veenhof C. Impact of curative treatment on the physical fitness of patients with esophageal cancer: A systematic review and meta-analysis. Eur J Surg Oncol 2021:S0748-7983(21)00685-5. [PMID: 34426032 DOI: 10.1016/j.ejso.2021.08.015] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
56 Rodrigues V, Landi F, Castro S, Mast R, Rodríguez N, Gantxegi A, Pradell J, López-Cano M, Armengol M. Is Sarcopenic Obesity an Indicator of Poor Prognosis in Gastric Cancer Surgery? A Cohort Study in a Western Population. J Gastrointest Surg 2021;25:1388-403. [PMID: 32661833 DOI: 10.1007/s11605-020-04716-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
57 Boshier PR, Klevebro F, Jenq W, Puccetti F, Muthuswamy K, Hanna GB, Low DE. Long-term variation in skeletal muscle and adiposity in patients undergoing esophagectomy. Dis Esophagus 2021:doab016. [PMID: 33822916 DOI: 10.1093/dote/doab016] [Reference Citation Analysis]
58 Lakenman P, Ottens-Oussoren K, Witvliet-van Nierop J, van der Peet D, de van der Schueren M. Handgrip Strength Is Associated With Treatment Modifications During Neoadjuvant Chemoradiation in Patients With Esophageal Cancer. Nutr Clin Pract 2017;32:652-7. [PMID: 28459652 DOI: 10.1177/0884533617700862] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
59 Levolger S, van Vledder M, Alberda W, Verhoef C, de Bruin R, Ijzermans J, Burger J. Muscle wasting and survival following pre-operative chemoradiotherapy for locally advanced rectal carcinoma. Clinical Nutrition 2018;37:1728-35. [DOI: 10.1016/j.clnu.2017.06.028] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
60 Menezes TM, Dias MO, Dos Reis R, Elias J Jr, Lucchesi FR, Araujo RLC. Prognostic value of muscle depletion assessed by computed tomography for surgical outcomes of cancer patients undergoing total esophagectomy and gastrectomy. J Surg Oncol 2020;121:814-22. [PMID: 31898327 DOI: 10.1002/jso.25822] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
61 Daly LE, Prado CM, Ryan AM. A window beneath the skin: how computed tomography assessment of body composition can assist in the identification of hidden wasting conditions in oncology that profoundly impact outcomes. Proc Nutr Soc 2018;77:135-51. [PMID: 29745361 DOI: 10.1017/S0029665118000046] [Cited by in Crossref: 33] [Cited by in F6Publishing: 14] [Article Influence: 11.0] [Reference Citation Analysis]
62 Han J, Harrison L, Patzelt L, Wu M, Junker D, Herzig S, Berriel Diaz M, Karampinos DC. Imaging modalities for diagnosis and monitoring of cancer cachexia. EJNMMI Res 2021;11:94. [PMID: 34557972 DOI: 10.1186/s13550-021-00834-2] [Reference Citation Analysis]
63 Zhou C, Foster B, Hagge R, Foster C, Lenchik L, Chaudhari AJ, Boutin RD. Opportunistic body composition evaluation in patients with esophageal adenocarcinoma: association of survival with 18F-FDG PET/CT muscle metrics. Ann Nucl Med 2020;34:174-81. [PMID: 31823231 DOI: 10.1007/s12149-019-01429-7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 2.7] [Reference Citation Analysis]
64 Sugimoto M, Farnell MB, Nagorney DM, Kendrick ML, Truty MJ, Smoot RL, Chari ST, Moynagh MR, Petersen GM, Carter RE, Takahashi N. Decreased Skeletal Muscle Volume Is a Predictive Factor for Poorer Survival in Patients Undergoing Surgical Resection for Pancreatic Ductal Adenocarcinoma. J Gastrointest Surg. 2018;22:831-839. [PMID: 29392613 DOI: 10.1007/s11605-018-3695-z] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]
65 Tegels JJ, van Vugt JL, Reisinger KW, Hulsewé KW, Hoofwijk AG, Derikx JP, Stoot JH. Sarcopenia is highly prevalent in patients undergoing surgery for gastric cancer but not associated with worse outcomes. J Surg Oncol 2015;112:403-7. [PMID: 26331988 DOI: 10.1002/jso.24015] [Cited by in Crossref: 67] [Cited by in F6Publishing: 65] [Article Influence: 9.6] [Reference Citation Analysis]
66 Horii N, Sawda Y, Kumamoto T, Tsuchiya N, Murakami T, Yabushita Y, Honma Y, Matsuyama R, Morioka D, Akiyama H, Endo I. Impact of intramuscular adipose tissue content on short- and long-term outcomes of hepatectomy for colorectal liver metastasis: a retrospective analysis. World J Surg Oncol 2020;18:68. [PMID: 32264904 DOI: 10.1186/s12957-020-01836-5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
67 Schizas D, Frountzas M, Lidoriki I, Spartalis E, Toutouzas K, Dimitroulis D, Liakakos T, Mylonas KS. Sarcopenia does not affect postoperative complication rates in oesophageal cancer surgery: a systematic review and meta-analysis. Ann R Coll Surg Engl 2020;102:120-32. [PMID: 31508983 DOI: 10.1308/rcsann.2019.0113] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
68 Takamori S, Toyokawa G, Okamoto T, Shimokawa M, Kinoshita F, Kozuma Y, Matsubara T, Haratake N, Akamine T, Takada K, Katsura M, Hirai F, Shoji F, Tagawa T, Oda Y, Honda H, Maehara Y. Clinical Impact and Risk Factors for Skeletal Muscle Loss After Complete Resection of Early Non-small Cell Lung Cancer. Ann Surg Oncol 2018;25:1229-36. [PMID: 29327178 DOI: 10.1245/s10434-017-6328-y] [Cited by in Crossref: 22] [Cited by in F6Publishing: 27] [Article Influence: 5.5] [Reference Citation Analysis]
69 Kawai M, Hirono S, Okada K, Miyazawa M, Shimizu A, Kitahata Y, Kobayashi R, Ueno M, Hayami S, Tanioka K, Yamaue H. Low lymphocyte monocyte ratio after neoadjuvant therapy predicts poor survival after pancreatectomy in patients with borderline resectable pancreatic cancer. Surgery 2019;165:1151-60. [DOI: 10.1016/j.surg.2018.12.015] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 5.3] [Reference Citation Analysis]
70 Boshier PR, Klevebro F, Schmidt A, Han S, Jenq W, Puccetti F, Seesing MFJ, Baracos VE, Low DE. Impact of Early Jejunostomy Tube Feeding on Clinical Outcome and Parameters of Body Composition in Esophageal Cancer Patients Receiving Multimodal Therapy. Ann Surg Oncol 2022. [PMID: 35616747 DOI: 10.1245/s10434-022-11754-3] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
71 Sakai M, Sohda M, Uchida S, Yamaguchi A, Watanabe T, Saito H, Ubukata Y, Nakazawa N, Kuriyama K, Sano A, Ogawa H, Yokobori T, Shirabe K, Saeki H. Impact of the Ratio of Visceral Fat Area (VFA) to Psoas Muscle Area (PMA) (V/P Ratio) on Survival for Surgically Resected Esophageal Cancer. Ann Surg Oncol 2022. [PMID: 35258768 DOI: 10.1245/s10434-022-11497-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
72 Huang T, Chou S, Lin Y, Li S, Chen Y, Lu H, Lo C, Fang F, Chiu Y, Chou Y, Wang Y. The Impact of Weight Loss during Chemoradiotherapy for Unresectable Esophageal Cancer: Real-World Results. Life 2022;12:706. [DOI: 10.3390/life12050706] [Reference Citation Analysis]
73 Ma DW, Cho Y, Jeon MJ, Kim JH, Lee IJ, Youn YH, Park JJ, Jung DH, Park H, Lee CG, Kim JW, Jeung HC. Relationship Between Sarcopenia and Prognosis in Patient With Concurrent Chemo-Radiation Therapy for Esophageal Cancer. Front Oncol 2019;9:366. [PMID: 31139564 DOI: 10.3389/fonc.2019.00366] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
74 Silveira EA, da Silva Filho RR, Spexoto MCB, Haghighatdoost F, Sarrafzadegan N, de Oliveira C. The Role of Sarcopenic Obesity in Cancer and Cardiovascular Disease: A Synthesis of the Evidence on Pathophysiological Aspects and Clinical Implications. Int J Mol Sci 2021;22:4339. [PMID: 33919368 DOI: 10.3390/ijms22094339] [Reference Citation Analysis]
75 Bitencourt AGV, Miola TM, Souza JO, da Conceição ELS, Coimbra FJF, Barbosa PNVP. Computed tomography-measured body composition: correlation with postoperative morbidity and mortality in patients with gastroesophageal cancer. Radiol Bras 2019;52:351-5. [PMID: 32047327 DOI: 10.1590/0100-3984.2019.0009] [Reference Citation Analysis]
76 Derstine BA, Holcombe SA, Ross BE, Wang NC, Su GL, Wang SC. Skeletal muscle cutoff values for sarcopenia diagnosis using T10 to L5 measurements in a healthy US population. Sci Rep 2018;8:11369. [PMID: 30054580 DOI: 10.1038/s41598-018-29825-5] [Cited by in Crossref: 104] [Cited by in F6Publishing: 91] [Article Influence: 26.0] [Reference Citation Analysis]
77 Takamori S, Tagawa T, Toyokawa G, Shimokawa M, Kinoshita F, Kozuma Y, Matsubara T, Haratake N, Akamine T, Hirai F, Honda H, Maehara Y. Prognostic Impact of Postoperative Skeletal Muscle Decrease in Non-Small Cell Lung Cancer. The Annals of Thoracic Surgery 2020;109:914-20. [DOI: 10.1016/j.athoracsur.2019.09.035] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
78 Mönig S, van Hootegem S, Chevallay M, Wijnhoven BPL. The role of surgery in advanced disease for esophageal and junctional cancer. Best Pract Res Clin Gastroenterol 2018;36-37:91-6. [PMID: 30551863 DOI: 10.1016/j.bpg.2018.11.002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
79 Aoyama T. Perioperative body composition changes in the multimodal treatment of gastrointestinal cancer. Surg Today 2020;50:217-22. [PMID: 31028458 DOI: 10.1007/s00595-019-01815-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
80 Ackermans LL, Volmer L, Timmermans QM, Brecheisen R, Damink SMO, Dekker A, Loeffen D, Poeze M, Blokhuis TJ, Wee L, Bosch JAT. Clinical evaluation of automated segmentation for body composition analysis on abdominal L3 CT slices in polytrauma patients. Injury 2022. [DOI: 10.1016/j.injury.2022.05.004] [Reference Citation Analysis]
81 Furuta M, Yokota T, Tsushima T, Todaka A, Machida N, Hamauchi S, Yamazaki K, Fukutomi A, Kawai S, Kawabata T, Onozawa Y, Yasui H. Comparison of enteral nutrition with total parenteral nutrition for patients with locally advanced unresectable esophageal cancer harboring dysphagia in definitive chemoradiotherapy. Jpn J Clin Oncol 2019;49:910-8. [PMID: 31219161 DOI: 10.1093/jjco/hyz089] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
82 Ryan AM, Prado CM, Sullivan ES, Power DG, Daly LE. Effects of weight loss and sarcopenia on response to chemotherapy, quality of life, and survival. Nutrition 2019;67-68:110539. [PMID: 31522087 DOI: 10.1016/j.nut.2019.06.020] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 11.0] [Reference Citation Analysis]
83 Panje CM, Höng L, Hayoz S, Baracos VE, Herrmann E, Garcia Schüler H, Meier UR, Henke G, Schacher S, Hawle H, Gérard MA, Ruhstaller T, Plasswilm L; Swiss Group for Clinical Cancer Research (SAKK). Skeletal muscle mass correlates with increased toxicity during neoadjuvant radiochemotherapy in locally advanced esophageal cancer: A SAKK 75/08 substudy. Radiat Oncol 2019;14:166. [PMID: 31511012 DOI: 10.1186/s13014-019-1372-3] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
84 Christensen JF, Simonsen C, Banck-Petersen A, Thorsen-Streit S, Herrstedt A, Djurhuus SS, Egeland C, Mortensen CE, Kofoed SC, Kristensen TS, Garbyal RS, Pedersen BK, Svendsen LB, Højman P, de Heer P. Safety and feasibility of preoperative exercise training during neoadjuvant treatment before surgery for adenocarcinoma of the gastro-oesophageal junction. BJS Open 2019;3:74-84. [PMID: 30734018 DOI: 10.1002/bjs5.50110] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]
85 Okuno M, Goumard C, Kopetz S, Vega EA, Joechle K, Mizuno T, Tzeng CD, Chun YS, Lee JE, Vauthey J, Aloia TA, Conrad C. Loss of muscle mass during preoperative chemotherapy as a prognosticator for poor survival in patients with colorectal liver metastases. Surgery 2019;165:329-36. [DOI: 10.1016/j.surg.2018.07.031] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 3.7] [Reference Citation Analysis]
86 Paireder M, Asari R, Kristo I, Rieder E, Tamandl D, Ba-Ssalamah A, Schoppmann SF. Impact of sarcopenia on outcome in patients with esophageal resection following neoadjuvant chemotherapy for esophageal cancer. Eur J Surg Oncol 2017;43:478-84. [PMID: 28024944 DOI: 10.1016/j.ejso.2016.11.015] [Cited by in Crossref: 63] [Cited by in F6Publishing: 62] [Article Influence: 10.5] [Reference Citation Analysis]
87 Wang B, Jiang X, Tian D, Geng W. Enteral nutritional support in patients undergoing chemoradiotherapy for esophageal carcinoma. Future Oncol 2020;16:2949-57. [PMID: 32857598 DOI: 10.2217/fon-2020-0181] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
88 Yassaie SS, Keane C, French SJH, Al‐herz FAJ, Young MK, Gordon AC. Decreased total psoas muscle area after neoadjuvant therapy is a predictor of increased mortality in patients undergoing oesophageal cancer resection. ANZ Journal of Surgery 2017;89:515-9. [DOI: 10.1111/ans.15106] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
89 Persson J, Fagevik Olsén M, Iresjö B, Smedh U. Body composition, sarcopenia, and quality of life in patients with oesophageal cancer before resection surgery and at follow‐up: a cohort study. JCSM Clinical Reports 2020;5:16-26. [DOI: 10.1002/crt2.9] [Reference Citation Analysis]
90 Yoon HG, Oh D, Noh JM, Cho WK, Sun JM, Kim HK, Zo JI, Shim YM, Kim K. Machine learning model for predicting excessive muscle loss during neoadjuvant chemoradiotherapy in oesophageal cancer. J Cachexia Sarcopenia Muscle 2021. [PMID: 34145771 DOI: 10.1002/jcsm.12747] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
91 Boshier PR, Heneghan R, Markar SR, Baracos VE, Low DE. Assessment of body composition and sarcopenia in patients with esophageal cancer: a systematic review and meta-analysis. Diseases of the Esophagus 2018;31. [DOI: 10.1093/dote/doy047] [Cited by in Crossref: 36] [Cited by in F6Publishing: 40] [Article Influence: 9.0] [Reference Citation Analysis]
92 Maeda N, Shirakawa Y, Tanabe S, Sakurama K, Noma K, Fujiwara T. Skeletal muscle loss in the postoperative acute phase after esophageal cancer surgery as a new prognostic factor. World J Surg Oncol 2020;18:143. [PMID: 32591002 DOI: 10.1186/s12957-020-01908-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]